Linvesta EMP 10mg/5mg Tablets
Pay in 3 Installments of
Rs.
268
JazzCash
easypaisa
NayaPay
Bank transfer
Cash on Delivery
Description
Linvesta EMP 10mg/5mg Tablets contain Empagliflozin 10mg and Linagliptin 5mg — a fixed-dose combination of two distinct antidiabetic classes. Empagliflozin is an SGLT2 inhibitor that reduces blood glucose by promoting urinary glucose excretion; Linagliptin is a DPP-4 inhibitor that enhances insulin secretion in a glucose-dependent manner. Together they provide complementary, well-tolerated glycaemic control for adults with Type 2 diabetes.
This combination is particularly beneficial for patients who require dual therapy beyond metformin, or where individual agents at adequate doses are not achieving target HbA1c. Empagliflozin also carries proven cardiovascular and renal benefits in high-risk patients.
Common side effects include urinary tract infections, genital mycotic infections, and mild hypoglycaemia (especially if combined with sulphonylureas). Rare but serious risks include diabetic ketoacidosis and Fournier's gangrene — seek immediate medical attention if these are suspected.
Order Linvesta EMP 10mg/5mg from Derma.pk — a licensed pharmacy in Pakistan. Visit our General Medicines collection. Prescription required. Send to sales@derma.pk or WhatsApp +92-320-5999650. Nationwide delivery available.
Usage & Benefits
- Dual-mechanism: SGLT2 inhibitor + DPP-4 inhibitor for broader blood glucose control
- Empagliflozin reduces HbA1c by promoting urinary glucose excretion
- Linagliptin enhances insulin secretion in a glucose-dependent, low-hypoglycaemia manner
- Empagliflozin proven to reduce cardiovascular death and hospitalisation in high-risk patients
- Convenient fixed-dose combination simplifies Type 2 diabetes management
How To Use
Use only as directed by your healthcare provider.
1. Take one tablet daily, with or without food, at the same time each day.
2. Swallow whole with a full glass of water.
3. Stay well hydrated throughout the day.
4. Monitor blood glucose regularly and report any unusual symptoms to your doctor.
5. Do not stop or adjust the dose without consulting your physician.
FAQs
What does Linvesta EMP 10mg/5mg contain?
It contains Empagliflozin 10mg (SGLT2 inhibitor) and Linagliptin 5mg (DPP-4 inhibitor) — two complementary antidiabetic agents in a single tablet.
Is Linvesta EMP only for Type 2 diabetes?
Yes. It is approved for adults with Type 2 diabetes mellitus. A valid prescription from your doctor is required.
Can Linvesta EMP cause low blood sugar on its own?
The risk is low when used without sulphonylureas or insulin. Linagliptin works in a glucose-dependent manner, reducing hypoglycaemia risk compared to some other antidiabetics.
